@article{3370a4c7c6e845d892a22c232ac5769e,
title = "Invited commentary: recommendation for a north american pediatric patch test series.",
abstract = "Given the increased recognition of pediatric allergic contact dermatitis and lack of patch testing consensus in children, we present a minimum basic 20-allergen North American pediatric series, for screening children ages 6-12 with suspected contact allergy.",
keywords = "Dermatitis, Allergic Contact/diagnosis, United States, Humans, Allergens/immunology, Child, Patch Tests",
author = "Jacob, \{Sharon E.\} and Shehla Admani and Herro, \{Elise M.\}",
note = "Funding Information: Conflict of Interest Sharon E. Jacob and Elise M. Herro served as investigators on the safety and efficacy of T.R.U.E. Test{\texttrademark} (Smart Practice; Phoenix, AZ) panels 1.1, 2.1, and 3.1 in children and adolescents, Pediatric Research Equity Act (PREA-1) trial. Dr. Jacob has also served as a consultant for Johnson \& Johnson. Sharon E. Jacob and Shehla Admani are currently investigators on the PREA-2 trial, and Shehla Admani is a research fellow at UCSD/Rady Children{\textquoteright}s Hospital funded by a grant from the National Psoriasis Foundation.",
year = "2014",
month = jun,
doi = "10.1007/s11882-014-0444-6",
language = "English",
volume = "14",
journal = "Current allergy and asthma reports",
issn = "1529-7322",
number = "6",
}